Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Orthopedic Bone Cement and Casting Materials Pipeline Market Report Overview

Bone cement is a fixing material used to fill in spaces between an orthopedic prosthesis and the bone stock. It helps to restore functionality; provides elasticity to the zone between the prosthesis and the bone stock; and maintains the mechanical stability of the prosthesis. Meanwhile, casting materials are used to immobilize the part of the fractured long bones to increase the healing. The casting material can be either Fiberglass or Plaster of Paris (POP) Bandage

The orthopedic bone cement and casting materials pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Bone Cement

·       Casting Materials

·       Antibiotic Bone Cement

·       Nonantibiotic Bone Cement

·       Cast Application and Removal System

Key Territories ·       The United States

·       Europe

·       Canada

·       China

·       Israel

Key Regulatory Paths ·       510(k)

·       CE

·       MDL

·       BOPA

·       NMPA

Leading Companies ·       Amotio BV

·       Biofix Medical Technologies

·       Bone-Rad Therapeutics, Inc.

·       Chinese Academy of Sciences

·       Dalhousie University

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Orthopedic Bone Cement and Casting Materials Pipeline Market by Segments

The key segments of the orthopedic bone cement and casting materials pipeline market are bone cement, casting materials, antibiotic bone cement, nonantibiotic bone cement, and cast application and removal system. As of November 2024, bone cement accounts for the highest share of pipeline products.

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Segments, 2024 (%)

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Orthopedic Bone Cement and Casting Materials Pipeline Market, Download a Free Report Sample

Orthopedic Bone Cement and Casting Materials Pipeline Market Segmentation by Territories

A few of the key territories in the orthopedic bone cement and casting materials pipeline market are the United States, Europe, Canada, China, Israel, and others. As of November 2024, the US accounts for the most pipeline products.

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Territories, 2024 (%)

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Orthopedic Bone Cement and Casting Materials Pipeline Market, Download a Free Report Sample

Orthopedic Bone Cement and Casting Materials Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the orthopedic bone cement and casting materials pipeline products market are 510(k), CE, MDL, BOPA, NMPA, and others. As of November 2024, 510(k) is the most followed pathway for pipeline products in the orthopedic bone cement and casting materials market.

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Orthopedic Bone Cement and Casting Materials Pipeline Market, Download a Free Report Sample

Orthopedic Bone Cement and Casting Materials Pipeline Market – Competitive Landscape

A few of the key companies associated with the orthopedic bone cement and casting materials pipeline market are Amotio BV, Biofix Medical Technologies, Bone-Rad Therapeutics, Inc., Chinese Academy of Sciences, Dalhousie University, and others.

Amotio BV:  Headquartered in Amsterdam, Noord-Holland, the Netherlands, Amotio BV operates within the pharmaceuticals and healthcare industry. It specifically focuses on medical devices for orthopedics. The company specializes in designing, manufacturing, and maintaining orthopedic devices.  

Chinese Academy of Sciences: Headquartered in Beijing, China, CAS is a scientific institution that focuses on research and development in high technology and natural sciences. The organization offers to conduct scientific research, foster innovation, and provide higher education. The company serves academic institutions, government agencies, and industries that apply its research in fields like environmental science, physics, and chemistry.

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Companies, 2024

Orthopedic Bone Cement and Casting Materials Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Orthopedic Bone Cement and Casting Materials Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Orthopedic Bone Cement and Casting Materials Pipeline Market Segments Outlook (2024)

  • Bone Cement
  • Casting Materials
  • Antibiotic Bone Cement
  • Nonantibiotic Bone Cement
  • Cast Application and Removal System

Orthopedic Bone Cement and Casting Materials Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe
  • Canada
  • China
  • Israel

Orthopedic Bone Cement and Casting Materials Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • MDL
  • BOPA
  • NMPA

Scope

This report provides:

  • Extensive coverage of the orthopedic bone cement and casting materials under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of orthopedic bone cement and casting materials and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of orthopedic bone cement and casting materials under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Amotio BV
Biofix Medical Technologies
Bone-Rad Therapeutics, Inc.
Chinese Academy of Sciences
Dalhousie University
DePuy Synthes Inc
Exactech Inc
Graftys SA
Hyalex Orthopaedics Inc
Inossia AB
Maxigen Biotech Inc
Medical Compression Systems (DBN) Ltd
MediPrint
Moroxite F AB
National University of Science and Technology MiSiS
Next Casting Technologies
Onbone Oy
OSARTIS GmbH
Osseon Therapeutics Inc
Ozics AG
Queen Mary University of London
Queen's University Belfast
Setbone Medical Ltd
Shenzhen Healthemes Biotechnology Co Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stryker Corp
University of Limerick
University of Missouri
University of Pittsburgh
Zimmer Biomet Holdings Inc
Zimmer GmbH

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Orthopedic Bone Cement and Casting Materials Overview

3 Products under Development

3.1 Orthopedic Bone Cement and Casting Materials – Pipeline Products by Stage of Development

3.2 Orthopedic Bone Cement and Casting Materials – Pipeline Products by Segment

3.3 Orthopedic Bone Cement and Casting Materials – Pipeline Products by Territory

3.4 Orthopedic Bone Cement and Casting Materials – Pipeline Products by Regulatory Path

3.5 Orthopedic Bone Cement and Casting Materials – Pipeline Products by Estimated Approval Date

3.6 Orthopedic Bone Cement and Casting Materials – Ongoing Clinical Trials

4 Orthopedic Bone Cement and Casting Materials – Pipeline Products under Development by Companies

4.1 Orthopedic Bone Cement and Casting Materials Companies – Pipeline Products by Stage of Development

4.2 Orthopedic Bone Cement and Casting Materials – Pipeline Products by Stage of Development

5 Orthopedic Bone Cement and Casting Materials Companies and Product Overview

5.1 Amotio BV Company Overview

5.1.1 Amotio BV Pipeline Products & Ongoing Clinical Trials Overview

5.2 Biofix Medical Technologies Company Overview

5.2.1 Biofix Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview

5.3 Bone-Rad Therapeutics, Inc. Company Overview

5.3.1 Bone-Rad Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.4 Chinese Academy of Sciences Company Overview

5.4.1 Chinese Academy of Sciences Pipeline Products & Ongoing Clinical Trials Overview

5.5 Dalhousie University Company Overview

5.5.1 Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview

5.6 DePuy Synthes Inc Company Overview

5.6.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview

5.7 Exactech Inc Company Overview

5.7.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview

5.8 Graftys SA Company Overview

5.8.1 Graftys SA Pipeline Products & Ongoing Clinical Trials Overview

5.9 Hyalex Orthopaedics Inc Company Overview

5.9.1 Hyalex Orthopaedics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.10 Inossia AB Company Overview

5.10.1 Inossia AB Pipeline Products & Ongoing Clinical Trials Overview

5.11 Maxigen Biotech Inc Company Overview

5.11.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

5.12 Medical Compression Systems (DBN) Ltd Company Overview

5.12.1 Medical Compression Systems (DBN) Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.13 MediPrint Company Overview

5.13.1 MediPrint Pipeline Products & Ongoing Clinical Trials Overview

5.14 Moroxite F AB Company Overview

5.14.1 Moroxite F AB Pipeline Products & Ongoing Clinical Trials Overview

5.15 National University of Science and Technology MiSiS Company Overview

5.15.1 National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview

5.16 Next Casting Technologies Company Overview

5.16.1 Next Casting Technologies Pipeline Products & Ongoing Clinical Trials Overview

5.17 Onbone Oy Company Overview

5.17.1 Onbone Oy Pipeline Products & Ongoing Clinical Trials Overview

5.18 OSARTIS GmbH Company Overview

5.18.1 OSARTIS GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.19 Osseon Therapeutics Inc Company Overview

5.19.1 Osseon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.20 Ozics AG Company Overview

5.20.1 Ozics AG Pipeline Products & Ongoing Clinical Trials Overview

5.21 Queen Mary University of London Company Overview

5.21.1 Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview

5.22 Queen’s University Belfast Company Overview

5.22.1 Queen’s University Belfast Pipeline Products & Ongoing Clinical Trials Overview

5.23 Setbone Medical Ltd Company Overview

5.23.1 Setbone Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.24 Shenzhen Healthemes Biotechnology Co Ltd Company Overview

5.24.1 Shenzhen Healthemes Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

5.25.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

5.26 Stryker Corp Company Overview

5.26.1 Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview

5.27 University of Limerick Company Overview

5.27.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview

5.28 University of Missouri Company Overview

5.28.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview

5.29 University of Pittsburgh Company Overview

5.29.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

5.30 Zimmer Biomet Holdings Inc Company Overview

5.30.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview

5.31 Zimmer GmbH Company Overview

5.31.1 Zimmer GmbH Pipeline Products & Ongoing Clinical Trials Overview

6 Orthopedic Bone Cement and Casting Materials- Recent Developments

6.1 Oct 24, 2024: Essity Publishes Interim Report for Q3 2024

6.2 Oct 09, 2024: Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results

6.3 Oct 08, 2024: Embla Medical: Conference Call Details for Q3 2024

6.4 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results

6.5 Sep 30, 2024: Xelite Biomed Receives 510(K) Clearance For VertehighFix High Viscosity Spinal Bone Cement System

6.6 Sep 02, 2024: Smith+Nephew Elevates Harshad Jadhav to a New Leadership Role

6.7 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.8 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.9 Aug 07, 2024: Zimmer Biomet Announces Second Quarter 2024 Financial Results

6.10 Jul 31, 2024: ATEC Reports Second Quarter 2024 Financial Results And Raises Full-Year Guidance

6.11 Jul 10, 2024: ATEC to Report Second Quarter Financial Results on July 31, 2024

6.12 Jul 09, 2024: Embla Medical: Conference Call for Q2 2024

6.13 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024

6.14 Jun 25, 2024: Medacta International Receives 510(K) Clearance For Meta+ Bone Cement

6.15 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.16 Apr 23, 2024: OsteoRemedies Obtains Expanded Indications for SPECTRUM Dual Antibiotic Bone Cement

6.17 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.18 Feb 21, 2024: Ossur hf: Annual General Meeting 13 March 2024

6.19 Feb 12, 2024: Smith+Nephew to Attend AAOS 2024 Annual Meeting

6.20 Jan 04, 2024: OsteoRemedies Receives 510(k) Clearance for SPECTRUM GV Bone Cement

6.21 Dec 14, 2023: Strategic Review of the Consumer Tissue Private Label Europe Business Concluded

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Stage of Development

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Segment

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Territory

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Regulatory Path

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Estimated Approval Date

Orthopedic Bone Cement and Casting Materials – Ongoing Clinical Trials

Orthopedic Bone Cement and Casting Materials Companies – Pipeline Products by Stage of Development

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Stage of Development

Amotio BV Pipeline Products & Ongoing Clinical Trials Overview

Precision Bone Cement Removal Device – Product Status

Precision Bone Cement Removal Device – Product Description

Biofix Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview

Injectable Glass Ionomer Cement – Product Status

Injectable Glass Ionomer Cement – Product Description

Bone-Rad Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Spine-Rad Brachytherapy Bone Cement – Product Status

Spine-Rad Brachytherapy Bone Cement – Product Description

Chinese Academy of Sciences Pipeline Products & Ongoing Clinical Trials Overview

BG Bone Cement – Product Status

BG Bone Cement – Product Description

Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview

Minimally Invasive System – Bone Augmentation – Product Status

Minimally Invasive System – Bone Augmentation – Product Description

DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview

Statin Eluting Bone Cements – Product Status

Statin Eluting Bone Cements – Product Description

Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview

Cemex Bone Cement – Product Status

Cemex Bone Cement – Product Description

Graftys SA Pipeline Products & Ongoing Clinical Trials Overview

GRFT-M03 – Product Status

GRFT-M03 – Product Description

GRFT-M05 – Product Status

GRFT-M05 – Product Description

Hyalex Orthopaedics Inc Pipeline Products & Ongoing Clinical Trials Overview

Hyalex Bone Cement – Product Status

Hyalex Bone Cement – Product Description

Inossia AB Pipeline Products & Ongoing Clinical Trials Overview

V-Flex – Product Status

V-Flex – Product Description

Inossia AB – Ongoing Clinical Trials Overview

V-Flex – A Multicentre, Single-blind, RCT to Document the Safety and Efficacy of the Use of a Bone Cement With or Without Inossia Cement Softener for Patients With Vertebral Compression Fractures

Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

MaxCement – Product Status

MaxCement – Product Description

Medical Compression Systems (DBN) Ltd Pipeline Products & Ongoing Clinical Trials Overview

ActiveCast – Product Status

ActiveCast – Product Description

MediPrint Pipeline Products & Ongoing Clinical Trials Overview

NovaCast – Product Status

NovaCast – Product Description

Moroxite F AB Pipeline Products & Ongoing Clinical Trials Overview

Fracture Fixation Device – Product Status

Fracture Fixation Device – Product Description

Moroxite F AB – Ongoing Clinical Trials Overview

Fracture Fixation Device – An Open-labelled Pilot Study to Evaluate Dynamic Hip Screw System (DHS) Augmented With a Biphasic Apatite Sulphate Combined With Systemic or Local Bisphosphonate for Trochanteric Femur Fracture

National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview

Ceramic Composite Polymer – Product Status

Ceramic Composite Polymer – Product Description

Next Casting Technologies Pipeline Products & Ongoing Clinical Trials Overview

Next Generation SmartCast – Product Status

Next Generation SmartCast – Product Description

Onbone Oy Pipeline Products & Ongoing Clinical Trials Overview

BIOCEMENT – Product Status

BIOCEMENT – Product Description

OSARTIS GmbH Pipeline Products & Ongoing Clinical Trials Overview

Ag Cement – Product Status

Ag Cement – Product Description

Osseon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

Monetite – Based Injectable Orthopaedic Cement – Product Status

Monetite – Based Injectable Orthopaedic Cement – Product Description

Ozics AG Pipeline Products & Ongoing Clinical Trials Overview

CompO6 Reinforced Bone Composite – Osteoporotic Fractures – Product Status

CompO6 Reinforced Bone Composite – Osteoporotic Fractures – Product Description

Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview

Calcium Phosphate Bone Cement – Product Status

Calcium Phosphate Bone Cement – Product Description

Queen’s University Belfast Pipeline Products & Ongoing Clinical Trials Overview

Spinal Cement – Product Status

Spinal Cement – Product Description

Setbone Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview

ReadySet Bone Cement – Product Status

ReadySet Bone Cement – Product Description

Shenzhen Healthemes Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Shenzhen Bone Cement – Product Status

Shenzhen Bone Cement – Product Description

Shenzhen Healthemes Biotechnology Co Ltd – Ongoing Clinical Trials Overview

Shenzhen Bone Cement – Clinical Trial for the Safety and Effectiveness of Bone Cement in Filling and Stabilizing Vertebral Body

Shenzhen Bone Cement – Clinical Trial for the Safety and Effectiveness of Bone Cement in Filling and Stabilizing Vertebral Body

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

BioCaS – Product Status

BioCaS – Product Description

Bone Cement – Product Status

Bone Cement – Product Description

Calcium Phosphate Bone Cement – Product Status

Calcium Phosphate Bone Cement – Product Description

Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview

Cortoss – Cranial Defects – Product Status

Cortoss – Cranial Defects – Product Description

University of Limerick Pipeline Products & Ongoing Clinical Trials Overview

Bioactive Adhesive Cement – Product Status

Bioactive Adhesive Cement – Product Description

Dual Calcium Phosphate Paste System – Product Status

Dual Calcium Phosphate Paste System – Product Description

Heracap – Product Status

Heracap – Product Description

University of Missouri Pipeline Products & Ongoing Clinical Trials Overview

Bone Cement – Product Status

Bone Cement – Product Description

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview

Nanostructured Smart Injectable Bone Cement – Product Status

Nanostructured Smart Injectable Bone Cement – Product Description

Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview

Cobalt Stage One Acrylic Spacer Cement – Product Status

Cobalt Stage One Acrylic Spacer Cement – Product Description

Zimmer GmbH Pipeline Products & Ongoing Clinical Trials Overview

Resurgent – Product Status

Resurgent – Product Description

Glossary

Figures

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Stage of Development

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Segment

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Territory

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Regulatory Path

Orthopedic Bone Cement and Casting Materials – Pipeline Products by Estimated Approval Date

Orthopedic Bone Cement and Casting Materials – Ongoing Clinical Trials

Frequently asked questions

Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.